Showing 2771-2780 of 4063 results for "".
- Vision Health Initiative Named a Mutual of America 2019 Community Partnership Award Winnerhttps://modernod.com/news/vision-health-initiative-named-a-mutual-of-america-2019-community-partnership-award-winner/2477094/Mutual of America announced that “Seeing the Future: Vision Health Initiative” was named a Merit Finalist award recipient of its 2019 Community Partnership Award competition. Seeing the Future: Vision Health Initiative was launched by Care For the Homeless (CFH) in 2016 after r
- Envision Announces Dates, Calls for Submissions for 2020 Conferenceshttps://modernod.com/news/envision-announces-dates-calls-for-submissions-for-2020-conferences/2477082/Envision announced that it is now accepting submissions for clinical education and research presentations for its two annual conferences in 2020: Envision Conference West, April 3-4, UT Health San Antonio Department of Occupational Therapy in San Antonio, Texas; and Envision Conference East, Augu
- American Academy of Optometry Foundation Announces the 2019 Vincent Salierno Scholarship Recipientshttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2019-vincent-salierno-scholarship-recipients/2477066/The American Academy of Optometry Foundation has announced the recipients of the 2019 Vincent Salierno Scholarships. The 2019 Vincent Salierno Scholarship recipients are: Kenneth Dang New England College of Optometry Mark Calixte
- CooperVision’s Michele Andrews, OD, Wins 2019 Theia Excellence Award from Women in Optometryhttps://modernod.com/news/coopervisions-michele-andrews-od-wins-2019-theia-excellence-award-from-women-in-optometry/2477045/For her significant contributions to the advancement of the industry and optometric profession, Michele Andrews, OD, Senior Director of Professional and Academic Affairs, North America, CooperVision, has been named a 2019 recipient of Women in Optometry’s Theia Excellence Awards. Dr. And
- CooperVision Shares Latest Contact Lens Research Results in Paper and Poster Presentations at Academy 2019https://modernod.com/news/coopervision-shares-latest-contact-lens-research-results-in-paper-and-poster-presentations-at-academy-2019/2477027/CooperVision clinicians and research partners are among the hundreds of presenters lined up to report their scientific advancements this week at Academy 2019 in Orlando. The latest company and company-sponsored research will be summarized in a series of papers and posters that encompass the compa
- Johnson & Johnson Vision to Showcase New Data and Interactive Experiences at 2019 American Academy of Optometry Annual Meetinghttps://modernod.com/news/johnson-johnson-vision-to-showcase-new-data-and-interactive-experiences-at-2019-american-academy-of-optometry-annual-meeting/2477026/Johnson & Johnson Vision will be sharing new science and clinical practice information to advance treatment paradigms and vision outcomes together with eye care professionals at the 2019 American Academy of Optometry Annual Meeting, held October 23 – 27 in Orlando, Florida. “We&#
- Regenxbio Announces Additional Positive Interim Phase 1/2a Trial Update for RGX-314 for the Treatment of Wet AMDhttps://modernod.com/news/regenxbio-announces-additional-positive-interim-phase-1-2a-trial-update-for-rgx-314-for-the-treatment-of-wet-amd/2476995/Regenxbio announced interim data from the ongoing phase 1/2a trial of RGX-314 for the treatment of wet age-related macular degeneration (AMD). The results were presented by Jeffrey S. Heier, MD, Co-President and Director of Retina Research at Ophthalmic Consultants
- Johnson & Johnson Vision Announces New Data, Products, and Physician Resources at AAO 2019https://modernod.com/news/johnson-johnson-vision-announces-new-data-products-and-physician-resources-at-aao-2019/2476994/Johnson & Johnson Vision is announcing a series of breakthrough data, technology, and products at the upcoming 2019 American Academy of Ophthalmology (AAO) annual meeting in San Francisco. The company will be announcing the FDA approval of the iDESIGN Refractive Studio Wavefront-guided PRK in
- Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in US IDE Trial for iStent infinitehttps://modernod.com/news/glaukos-achieves-pipeline-milestone-with-completion-of-patient-enrollment-in-us-ide-trial-for-istent-infinite/2476990/Glaukos announced the completion of patient enrollment in its FDA Investigational Device Exemption (IDE) trial for the iStent infinite Trabecular Micro-Bypass System. The iStent infinite is designed for use in a standalone procedure to reduce elevated IOP in refractory glaucoma patients. I
- Mynosys Secures $25 Million Investment; Names Rob Thornhill as CEOhttps://modernod.com/news/mynosys-secures-25-million-investment-names-rob-thornhill-as-ceo/2476976/Mynosys Cellular Devices, manufacturer of the Zepto cataract surgery device, announced it finalized a $25 million financing round, led by Decheng Capital, and named veteran ophthalmology industry executive Rob Thornhill as Chief Executive Officer. This financing provides capital to fuel U.